Bone Marrow TransplantationBone MarrowTransplantation, HomologousBone Marrow CellsGraft vs Host DiseaseTissue DonorsTransplantation, AutologousWhole-Body IrradiationBone and BonesLiver TransplantationGraft SurvivalAnemia, AplasticTransplantation ConditioningHematopoietic Stem Cell TransplantationLeukemiaTransplantation ChimeraTreatment OutcomeBusulfanKidney TransplantationBone Marrow PurgingLiving DonorsCombined Modality TherapyHistocompatibility TestingGraft RejectionCyclophosphamideHistocompatibilityHematopoietic Stem CellsTime FactorsRecurrenceTransplantation, IsogeneicMice, Inbred C57BLRetrospective StudiesBone Marrow DiseasesImmunosuppressive AgentsHematopoiesisRadiation ChimeraLeukemia, Myelogenous, Chronic, BCR-ABL PositiveFatal OutcomeLeukemia, Myeloid, AcuteBone Marrow ExaminationDonor SelectionSurvival AnalysisAcute DiseaseHematologic NeoplasmsRemission InductionT-LymphocytesPrecursor Cell Lymphoblastic Leukemia-LymphomaPrognosisHepatic Veno-Occlusive DiseaseTissue and Organ ProcurementBone RemodelingTransplantation ImmunologyFollow-Up StudiesBone Marrow NeoplasmsGraft vs Host ReactionLeukemia, MyeloidSurvival RateImmunosuppressionLeukocyte TransfusionLymphocyte DepletionHeart TransplantationStem Cell TransplantationAntineoplastic Combined Chemotherapy ProtocolsLymphoma, Non-HodgkinSevere Combined ImmunodeficiencyHLA AntigensChimeraColony-Forming Units AssayDisease-Free SurvivalMyelodysplastic SyndromesLung TransplantationCyclosporineActuarial AnalysisHematologic DiseasesBlood DonorsBone DensityLymphocyte TransfusionHodgkin DiseaseOrgan TransplantationNuclear FamilyMice, KnockoutCarmustineGraft vs Tumor EffectCell DifferentiationPancytopeniaMethotrexateProspective StudiesCytomegalovirus InfectionsLeukocyte CountGraft vs Leukemia EffectCytarabineSpleenGranulocyte Colony-Stimulating FactorPostoperative ComplicationsMice, Inbred BALB CBone ResorptionRisk FactorsMelphalanFlow CytometryEtoposide